Meltem Karacan Gölen

Meltem Karacan Gölen

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2024 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Open access
PDF file
MGMeltem Karacan Gölen
Meltem Karacan Gölen
ŞIŞaziye Melike Işık
Şaziye Melike Işık
VAVeysel Arıkan
Veysel Arıkan
Aim: Vascular dysfunction, oxidative stress and systemic inflammation are considered responsible for the pathophysiology of Obstructive sleep apnea syndrome (OSAS). It is thought that desaturation due to apnea–hypopnea attacks in OSAS patients activates inflammatory pathways. In this study, we aimed to reveal the relationship between inflammation parameters Systemic immune inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratios (PLR) severity of OSAS in patients who underwent polysomnography in our hospital’s sleep laboratory. Methods: We grouped our 171 patients who were followed up in our sleep laboratory with the diagnosis of OSAS according to their AHI values. We evaluated the correlation of SII, NLR, and PLR values obtained from the complete blood tests of our patients with OSAS diagnosis and OSAS severity. Results: The mean NLR, PLR and SII values of patients with OSAS were statistically significantly higher than those without OSAS (p < 0.05). A positive correlation of 18% was found between the presence of OSAS and the SII value (p = 0.016). No statistically significant difference was found when comparing OSAS severity and NLR, PLR and SII values (p > 0.05). Conclusion: We observed that SII, NLR and PLR parameters, which are rapidly assessable systemic inflammation markers of this process, were independently associated in patients diagnosed with OSAS and that there was no change in SII, NLR, and PLR parameters with OSAS severity.

22 December 2023 in Epilepsy & Behavior
Verified
Journal Article
Closed access
GAGönül Akdağ
Gönül Akdağ
SKSibel Canbaz Kabay
Sibel Canbaz Kabay
ADAylin Bican Demir
Aylin Bican Demir
EBEbru Ergin Bakar
Ebru Ergin Bakar
GKGüray Koç
Güray Koç
MÇMustafa Çetiner
Mustafa Çetiner

14 March 2025 in Brain and Behavior
Verified
Journal Article
Open access
MGMeltem Karacan Gölen
Meltem Karacan Gölen
KKKeziban Uçar Karabulut
Keziban Uçar Karabulut
MKMuhammed Kamiloğlu
Muhammed Kamiloğlu
AYAynur Yonar
Aynur Yonar
Background: The inflammatory response plays a central role in the clinical outcomes of cerebrovascular disease. The aim of this study was to investigate the clinical significance of pan‐immune‐inflammation value (PIV) in patients with acute ischemic stroke after mechanical thrombectomy (MT).Methods: The study included 201 patients who underwent MT. Blood samples taken from the patients before the procedure were evaluated and inflammation markers were calculated. Severity of stroke was assessed using the National Institute of Health Stroke Scale (NIHSS) scores on admission. Poor 3‐month functional outcome was defined as Modified Rankin Scale (mRS) scores of >2. Ischemic stroke types were classified according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classificationResults: In the logistic regression analysis, we observed that PIV was associated with a poor outcome. Post hoc multiple comparison tests revealed statistically significant differences in PIV between the stroke of other determined etiology and small‐vessel occlusion (178.00 vs. 74.89, p = 0.015 and p < 0.05, respectively), large artery atherosclerosis (178.00 vs. 95.51, p = 0.032 and p < 0.05, respectively), and cardioembolism (178.00 vs.107.97, p = 0.043 and p < 0.05) subtypes. There was a moderate positive statistically significant relationship at the 95% confidence level between NIHSS score and PIV (r = 0.696, p < 0.05).Conclusion: Our study revealed that PIV predicts a poor 3‐month prognosis in acute ischemic cerebrovascular disease after MT with a significantly better performance than the widely known systemic immune‐inflammation index, systemic inflammation response index, platelet/lymphocyte ratio, and neutrophil/lymphocyte ratio. PIV can be a novel prognostic marker indicating poor prognosis in patients treated with MT.

3 May 2023 in The European Research Journal
Verified
Journal Article
Open access
PDF file
MGMeltem Karacan Gölen
Meltem Karacan Gölen
DODilek Yılmaz Okuyan
Dilek Yılmaz Okuyan
Objectives: Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy of the upper extremity that affects activities of daily living. In our study, we aimed to reveal the relationship between CTS and BMI, and to evaluate symptom severity and functionality in these patients by using the Boston CTS questionnaire. Methods: In this study, 300 patients with CTS and 100 healthy individuals without CTS whose EMG was performed in our neurology clinic electrophysiology laboratory between June 2021 and December 2021, were included. BMI, SII index, and Boston CTS questionnaire findings were compared between patients diagnosed as having mild, moderate, and severe CTS (according to electrophysiologic evaluations) and a control group consisting of healthy individuals. Results: In our study, a statistically significant difference was observed between the CTS and control groups in terms of mean age (p < 0.001). When the increased BMI and SII parameters were compared, a statistically significant difference was observed between the control and CTS groups (p < 0.001 for both). In the multivariate logistic regression analysis, it was observed that the risk of CTS increased 1.566 times as BMI increased, and the risk of CTS increased 1.005 times as the SII index increased (p < 0.001 for both). Conclusions: We observed that increased BMI and advanced age were risk factors for CTS. In our study, in which the relationship between the SII index and CTS was evaluated for the first time, according to our findings, inflammation was thought to play a role in the pathophysiology of CTS.

20 September 2024 in Medicine
Verified
Journal Article
Open access
MGMeltem Karacan Gölen
Meltem Karacan Gölen
ŞIŞaziye Melike Işik
Şaziye Melike Işik
YouTube (YT) is one of the world’s most well recognized video-sharing platforms that appeals to large audiences and is used by individuals to educate themselves on disease diagnosis and treatment alternatives and to distribute health-related information. Videos were searched by typing the terms “migraine botox” and “botox treatment for migraine” on the YT search bar in English. A total of 50 videos were evaluated for each term. Two independent researchers viewed the videos and documented pertinent descriptive attributes of each video, such as the upload date, number of comments, number of dislikes, number of likes, and views. The videos were analyzed and the DISCERN Global Quality Scale (GQS), Journal of the American Medical Association (JAMA) quality, and reliability scores were recorded. A total of 100 videos were assessed. The mean DISCERN score was 3.09, the mean JAMA score was 2.11, and the mean GQS score was 3.25. According to the source, 32% of the videos were uploaded by university/nonprofit physicians or professional organizations. In addition, when the DISCERN, GQS, and JAMA scores of the videos uploaded by health professionals were examined, a statistically significant difference was observed (P = .002, P = .015, and P = .002, respectively). However, no statistically significant relationship was found for the Video Popularity Index score. The reliability and quality scores of the evaluated videos uploaded by healthcare professionals for migraine Botox treatment were high, but the frequency of viewership was low. In our analysis of migraine Botox treatment videos on YT, we observed that the information on migraine Botox treatment had a wide spectrum, high-quality content, and that there were videos that may mislead viewers. In conclusion, we believe that the platform is not sufficient in its entirety, and that it should be supported with renewed, fact-checked, easy-to-understand language, and video-duration optimized videos.

10 June 2026 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Open access
PDF file
YUYildiz Ucar
Yildiz Ucar
CICaner Incekas
Caner Incekas
KKKeziban Ucar Karabulut
Keziban Ucar Karabulut
MGMeltem Karacan Gölen
Meltem Karacan Gölen
Background: Obstructive sleep apnea syndrome (OSAS) has long been considered a predominantly male disorder; however, increasing evidence suggests substantial sex-related differences in clinical presentation and disease progression. Methods: This retrospective study included adult patients diagnosed with OSAS by polysomnography between January 2020 and January 2026. Demographic characteristics, polysomnographic findings, laboratory parameters, and echocardiographic measurements were analyzed. Systemic inflammation was assessed using the monocyte-to-HDL ratio, monocyte-to-LDL ratio, systemic immune-inflammation index (SII), systemic inflammatory response index (SIRI), and pan-immune-inflammation value (PIV). Results: A total of 230 patients were included (68.3% male, 31.7% female). Female patients were older and had higher body mass index at diagnosis ( p < 0.001). Mean and minimum oxygen saturation levels were significantly lower in women ( p < 0.01), who also exhibited higher pulmonary artery pressure and lower ejection fraction ( p < 0.001). In contrast, monocyte-based inflammatory indices (MON/HDL, MON/LDL, and SII) were significantly higher in men. No significant sex-related differences were observed for SIRI or PIV. Conclusion: OSAS demonstrates distinct sex-specific clinical and inflammatory phenotypes. While women tend to present at a later stage with more pronounced cardiopulmonary involvement, men exhibit a greater systemic inflammatory burden. These findings support the importance of incorporating sex-based considerations into diagnostic and therapeutic strategies for OSAS.